
Causal discovery platform maps vascular metabolic pathways
In data from 720,000 people, the self-evolving system evaluated 2,031 causal questions and identified blood pressure as a convergence node for vascular outcomes.
In data from over 720,000 human participants across 48 countries, researchers tested an automated discovery platform called DoAtlas-2 to map causal biomedical mechanisms. The platform integrates 771 resources spanning clinical phenotypes, medical imaging, physiological signals, eight molecular layers, and 4.7 million literature-derived records. DoAtlas-2 formulates questions from evidence gaps, prespecifies causal designs, and updates its network based on empirical results. The system systematically evaluated 2,031 research questions. In the Human Phenotype Project, an initial screening of 1,079 candidate pathway questions yielded statistical support for 756 across vascular, early-glycemic, and hepatic-metabolic systems. Specific analyses identified blood pressure as a convergence node connecting adiposity, hepatic, and lipid phenotypes to vascular outcomes, while an adiposity-inflammation-blood-pressure pathway was largely attenuated after joint adjustment for body mass index and smoking.
Why it matters
Clarifying causal networks across metabolic and vascular systems helps researchers pinpoint specific target mechanisms driving age-related vascular pathology. The framework also provides fully interpretable mediation pathways to predict vascular outcomes.
Caveats
The findings are reported in a preprint that has not yet been peer-reviewed, and the causal pathways are derived from observational population data rather than randomized trials.
The paper
DoAtlas-2: A Foundation for Self-Evolving Causal Biomedical Discovery
Li Y, Xia R, Zhang Y et al.
arXiv · 28 Sep 2026 · Preprint, not yet peer-reviewed

